ARKG vs JEPI
ARK Genomic Revolution ETF vs JPMorgan Equity Premium Income ETF
- • JEPI has the lower expense ratio at 0.35% vs 0.75% for ARKG.
- • JEPI pays a higher dividend yield (8.11%).
Side-by-side metrics
| Metric | ARKG | JEPI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.00% | 8.11% |
AUM Assets under management — bigger funds are typically more liquid. | $1.73B | $44.75B |
YTD return | 44.53% | 2.87% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.38 | 0.43 |
P/E ratio | — | 26.88 |
Last price | $43.17 | $56.64 |
Inception | — | — |
Issuer | ARK | JPMorgan |
ARKG top holdings
| TWST | Twist Bioscience Corp | 9.15% |
| TEM | Tempus AI Inc Class A common stock | 7.64% |
| ABSI | Absci Corp | 7.01% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 7.00% |
| CRSP | CRISPR Therapeutics AG | 6.56% |
| PSNL | Personalis Inc | 6.19% |
| BEAM | Beam Therapeutics Inc | 4.34% |
| GH | Guardant Health Inc | 4.28% |
| NTRA | Natera Inc | 4.11% |
| ILMN | Illumina Inc | 3.98% |
JEPI top holdings
| ABBV | AbbVie Inc | 1.73% |
| HWM | Howmet Aerospace Inc | 1.69% |
| JNJ | Johnson & Johnson | 1.66% |
| ETN | Eaton Corp PLC | 1.63% |
| TT | Trane Technologies PLC Class A | 1.61% |
| LRCX | Lam Research Corp | 1.56% |
| NVDA | NVIDIA Corp | 1.52% |
| AAPL | Apple Inc | 1.52% |
| ROST | Ross Stores Inc | 1.51% |
| GOOGL | Alphabet Inc Class A | 1.51% |
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.7B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 9.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About JEPI
JEPI (JPMorgan Equity Premium Income ETF) is Active equity income with covered-call overlay. Managed by JPMorgan, the fund carries $44.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 8.11%. Its largest holding is AbbVie Inc (ABBV), which represents 1.7% of the portfolio. Real Estate is the fund's largest sector exposure at 3.2%.